Vestibo: instructions for use and what it is needed for, price, reviews, analogues. Vestibo - effective relief of dizziness Vestibo how long can you take

Vestibo is medicinal product, dilates blood vessels and has a histamine-like effect. Effective for the treatment of pathologies of the vestibular apparatus, available in the form of tablets (24, 16, 14 and 8 mg).

Helps eliminate disorders of both the vestibular and cochlear apparatus: reduces the frequency and intensity of dizziness, reduces tinnitus, and helps improve hearing in cases of hearing loss. Does not have a sedative effect and does not cause drowsiness.

The active component is betahistine, a synthetic analogue of the natural mediator histamine. The substance has pronounced histamine activity and has a vasodilating effect.

Vestibo affects the vestibular apparatus and cochlear blood flow. It is the histaminergic system, to which the action of the active substance of the drug is directed, that is the main one in the functioning of the vestibular systems. Histaminergic neurons conduct impulses from receptors and vestibular nuclei.

The drug reduces the frequency and intensity of impulses in the system of neurons of the lateral vestibular nucleus. It also reduces the impulsive activity of ampullary receptors. Betahistine improves microcirculation, increases the permeability of capillary walls, stabilizes endolymphatic pressure during inner ear, and these effects are achieved due to its action on H1- histamine receptors precapillary sphincters of small vessels.

The therapeutic effect appears after 2 weeks, and sometimes only after several months of regular use of the drug, so treatment is usually long-term.

Indications for use

What is Vestibo 16\24 mg used for? According to the instructions for use, the drug is prescribed in the following cases:

• dizziness or ear pain associated with hydrocele;
• post-traumatic and infectious vestibular dysfunction;
• Meniere's disease;
• severe autonomic disorders due to dizziness of any etiology, including benign positional: vomiting or nausea, attacks of weakness and sweating;
• For complex treatment encephalopathies that arise after injuries, against the background of vertebrobasilar insufficiency, atherosclerosis;
• hearing loss, impaired orientation in space or balance due to pathology of the vestibular apparatus.

Instructions for use Vestibo 16\24 mg, dosage

Vestibo tablets should be swallowed without chewing and washed down with water. The drug should be taken with meals.

The dosage is determined by the doctor individually, depending on tolerability, severity of the disease, the patient’s weight and concomitant diseases.

• The standard dosage for adults is 8-16 mg 2-4 times a day.
• The maximum daily dose of the drug is 48 mg.

The therapeutic effect occurs several months after the start of treatment.

Side effects

The instructions warn about the possibility of developing the following side effects when prescribing Vestibo:

• development of dyspeptic symptoms,
• headache,
• allergic reactions, including itchy skin, urticaria, Quincke's edema.

In most cases, the drug is well tolerated, side effects occur rarely and are mild.

Contraindications

Vestibo is contraindicated in the following cases:

• any manifestations of individual intolerance to the drug that occurred previously;
• history of bronchial asthma or a tendency to bronchospasm;
• peptic ulcer of the stomach or duodenum in the acute stage;
• pheochromocytoma.

With caution and under medical supervision, Vestibo can be prescribed to pregnant women (2nd and 3rd trimesters), during lactation, patients with hypotension, with a stomach ulcer or duodenum.

Overdose

In case of overdose, patients may experience redness of the skin of the face and upper body, fever, headache, fainting, dizziness, severe tachycardia, decreased blood pressure, bronchospasm.

Analogues of Vestibo, price in pharmacies

If necessary, you can replace Vestibo with an analogue therapeutic effect- these are drugs:

1. Westicap,
2. Betagis,
3. Betahistine.

By ATX code:

• Asniton,
• Betahistine,
• Vertran,
• Tagista.

When choosing analogues, it is important to understand that instructions for use of Vestibo, price and reviews of drugs similar action do not apply. It is important to consult a doctor and not change the drug yourself.

Price in Russian pharmacies: Vestibo tablets 8 mg 30 pcs. – from 142 to 165 rubles, 16 mg 30 pcs. – from 239 to 270 rubles.

Store in a dry place, protected from light and out of reach of children, at a temperature not exceeding +25°C. Shelf life – 3 years. Sales in pharmacies by prescription.

The site provides background information for informational purposes only. Diagnosis and treatment of diseases must be carried out under the supervision of a specialist. All drugs have contraindications. Consultation with a specialist is required!

Vestibo drug

Vestibo– a synthetic drug that has a vasodilator and histamine-like effect. Histamine is a biologically active substance produced in the human body. It causes vasodilation and is involved in allergic reactions body. Betagistine(active ingredient Vestibo) is synthetic analogue histamine.

Vestibo has a stimulating effect on histamine receptors and thereby causes vasodilation in the inner ear, increases capillary permeability, increases blood flow and normalizes lymph pressure in the cochlear labyrinth and in the cochlea (anatomical parts of the inner ear).

Moreover, this medicine helps improve blood supply to the brain, increases the level of serotonin (a hormone that causes a state of emotional peace) and improves the conduction of impulses in nerve cells brain stem. Under the influence of the drug Vestibo, the severity and frequency of dizziness decreases, the sensation of tinnitus decreases, and hearing improves. In this case, drowsiness does not occur, reaction speed and the ability to concentrate are not impaired.

Vestibo is quickly absorbed from digestive tract and reaches maximum level in the blood 3 hours after consumption. Within a day, the drug is almost completely (up to 90%) excreted from the body in the urine.

Release forms

Vestibo is available in tablets containing 8 mg, 16 mg or 24 mg of Betahistine hydrochloride.

The tablets are placed in blisters. Packages of 3 blisters with 10 tablets or 2 blisters with 14 tablets are available.

Instructions for use Vestibo

Indications for use

• Vestibular disorders in infectious diseases;
• labyrinthine and vestibular disorders: tinnitus, headache, impaired coordination and balance in space, nausea and vomiting;
• post-traumatic vestibular disorders;
• acoustic neuritis;
• benign dizziness (positional, postoperative);
• diseases of the labyrinth of the inner ear (inflammation, dropsy);
• vertebrobasilar insufficiency;
• atherosclerotic lesions of cerebral vessels.

Contraindications

• Individual intolerance to the components of the drug;
• bronchial asthma and tendency to bronchospasms;
• peptic ulcer in the acute stage;
• 1st trimester of pregnancy and lactation period.

Prescribed with caution drug for women during pregnancy after 14 weeks, with peptic ulcer outside of exacerbation, with allergic diseases and low blood pressure.

Side effects

Vestibo is well tolerated; side effects are observed infrequently and are mild. In rare cases, the following reactions are possible:

• from the digestive system – nausea, vomiting;
• allergic manifestations in the form of skin rash and itching, Quincke's edema;
• from the nervous system – headache, drowsiness.

Vestibo treatment

How to take Vestibo?
The tablet should be swallowed whole, without crushing or chewing. The medicine should be taken during meals or immediately after meals with plenty of water.

There are no professional restrictions required when treating Vestibo, since the drug does not impair reaction speed and concentration.

Vestibo dosage
Vestibo 8 mg or 16 mg is prescribed 1 tablet 2-4 r. per day, and for 24 mg - 0.5-1 tablet 2 r. in a day. Maximum permissible dose– 48 mg per day. One-time and daily dose determined by the doctor taking into account the nature of the disease, the patient’s age and weight, and the presence of concomitant pathologies.

Vestibo treatment courses are quite long. The effect of taking the drug in the form of improvement is noted after 2 weeks of treatment and intensifies as the course continues. A sustained therapeutic effect occurs after using Vestibo for several months.

Overdose the drug manifests itself in the form of dizziness, headache, bronchospasm, nausea, vomiting, gait disturbance, convulsions, decreased blood pressure, increased heart rate,

Vestibo is a drug that taken for disorders of the vestibular apparatus.

Such deviations from the norm entail dizziness, nausea and the development of hearing problems, and, as a result, a decrease in hearing indicators. This drug is produced in Germany and Bulgaria in the form of tablets that have a round shape and the inscription “B8”.

The active ingredient in this drug is betahistine dihydrochloride. It is produced in tablets, each of which contains 8 mg, 16 mg or 24 mg active substance.

Pharmacological action

Vestibo is a drug that has similar properties to histamine.

The main active ingredient betahistine dihydrochloride has an effect mainly on the H1 and H3 receptors located in the inner ear, as well as on the vestibular nuclei of the central nervous system.

This substance also improves the flow of blood into the basilar arteries. And, acting as a substance that slows down the functioning of H3 receptors, betahistine dihydrochloride has a direct effect on the brain stem.

Renders positive action on the vestibular apparatus, normalizing its functioning and bringing it to a normal state. With its help, microcirculation of the capillaries of the inner ear improves, the frequency of dizziness and the degree of their intensity decreases.

Also headaches and tinnitus go away.

The drug Vestibo does not have sedative properties which means that it does not cause drowsiness and does not cause problems with concentration.

Pharmacokinetics of the drug

This drug is quite well and almost completely integrated into the gastrointestinal tract.

As a result of this, new substances are formed. The concentration of the active substance in the blood is very low, as a result of which all studies are carried out on the substance that is synthesized after using the drug Vestibo.

The maximum concentration of such a drug is achieved only an hour after it is taken orally. If you use this drug in an amount of 8-48 milligrams, then about 85% of the initial dose is registered in the urine. The drug is excreted in minute quantities through the kidneys or through feces.

Indications for use

Instructions for use of Vestibo indicate the following indications for use: medications:

Contraindications

Experts point to the following contraindications:

• hypersensitivity to the components of the drug;
• period of pregnancy and breastfeeding (the effect in this case has not yet been thoroughly studied);
• stomach ulcer;
• bronchial asthma;
• it is recommended to pay Special attention for use of the drug by children under 18 years of age.

Mechanism of action

The mechanism of action of the drug Vestibo cannot be called fully studied.

He improves blood circulation in the vessels of the inner ear. Active substance this drug has a certain effect on the occurrence of peak potentials in the neurons of the nuclei of the vestibular apparatus, which depend on the dose.

He promotes acceleration regeneration of vestibular function. Summarizing all these functions, we can say that they have a positive effect on the vestibular apparatus in cases of treatment of Meniere's syndrome and dizziness in cases of incorrect functioning of the vestibular apparatus.

Thus, Betahistine enhances the metabolism and elimination of histamine.

At the same time, it has the ability to block H3 receptors and this entails a decrease in their sensitivity.

Instructions for use

Let's study the instructions for use, which are the same for Vestibo 24, 16 and 8 mg.

Mode of application

For adults, the drug is prescribed in accordance with the degree of the disease, the body’s ability to perceive it normally, age, weight, and diseases that accompany it.

On average, the required dose is 8-16 mg 2 to 4 times a day. The treatment process itself takes a fairly long period and noticeable results can be observed only after a few months from the start of taking Vestibo. Maximum dose, which a person can take per day is 48 mg.

The doses in which the patient will need to take this drug are prescribed by the attending physician for each individual.

Release form of the drug

Vestibo is launched in the following forms:

• tablets containing 8 mg of the active substance betahistine dihydrochloride, are round, flat, colored White color and have a mark on one side “B8”;
• tablets containing 16 mg of the active substance betahistine dihydrochloride are round, flat, painted white and marked “B16” on one side and a line on the other;
• tablets containing 24 mg of the active substance betahistine dihydrochloride are biconvex in shape, white in color and have a line on one side.

Dosage

Necessary and acceptable doses:

• tablets containing 8 mg of active substance must be taken 1-2 tablets 3 times a day;
• tablets containing 16 mg of active substance must be taken 1 tablet 3 times a day;
• tablets containing 24 mg of active substance must be taken 1 tablet 2 times a day.

The maximum permissible dose that can be taken per day is 24-48 mg.

Overdose and additional instructions

Side effect

The drug Vestibo has quite a lot side effects, which are reflected in the work individual organs And systems:

• the immune system is affected by hypersensitivity reactions;
• it affects the digestive system in this way - nausea and depression are quite common;
• Sometimes there were complaints from patients about stomach upset, which disappeared when correct technique the drug with food or in cases of dose reduction;
• on general condition skin and subcutaneous layers, in very rare cases, a rash was observed;
• central nervous system in very rare cases, headaches and tendency to sleep were affected;
• The effect of this drug was also reflected on cardiovascular system in several cases where palpitations were observed;
• concerning respiratory system, then exacerbations of bronchial asthma were noticed;
• as well as a general deterioration in health in the form of fever.

special instructions

The effectiveness of treatment can be observed only a couple of months after starting treatment and taking medications.

Excessive addiction to alcohol may end up manifesting itself. Our experts studied why this condition is dangerous.

Convulsions, complete indifference and foaming at the mouth - this is what epilepsy is known for, first aid for an attack of which can save a person’s life. that everyone should know.

Drug interaction with alcohol

It is not recommended to use Vestibo in parallel with taking the drug. alcoholic drinks so as not to cause undesirable consequences, do not interfere with the mechanism of action of the drug and do not interfere with the healing process.

Interaction with other drugs

Use during pregnancy and lactation

The effect of Vestibo has not yet been thoroughly studied, so in these cases it is, in principle, not recommended to take it. But if there is a strong necessary, then only under the close supervision of the attending physician.

Concerning breastfeeding period, then there is no reliable information on this matter. Thus, we can say that the release of the substance betahistine into milk can lead to an unexpected threat to the life of the child.

Due to the fact that the drug has not yet been fully studied, we come to the conclusion that it is not recommended for children to take it.

Reviews from patients and doctors

Reviews from doctors and patients about the drug Vestibo are positive.

Reviews from doctors

Here are doctors' reviews about:

1. Vestibo has proven itself quite well due to its small list of contraindications and its accessibility to patients ( Slepakov P.R.).
2. In general, it normalizes the functioning of the vestibular apparatus well. The only drawback– this is its insufficient study. Because of this, it should not be prescribed to children or during pregnancy. (Romanova V.S.).

The medicinal drug Vestibo is an artificial analogue of histamine. The drug helps improve the functioning of the vestibular apparatus, dilate blood vessels and stimulate cochlear blood flow, reduce the frequency of attacks of dizziness and eliminate tinnitus. Vestibo is accepted at various pathologies vestibular or labyrinthine nature, including infectious and post-traumatic etiology. The drug is contraindicated in patients suffering from exacerbation of ulcerations of the duodenum and/or stomach, pheochromocytoma, bronchial asthma, hypersensitivity, as well as women during the first trimester of pregnancy and children under 18 years of age.

Dosage form

As dosage form The release of the drug Vestibo are white (or almost white) biconvex tablets, round shape with a dividing strip applied on one side.

The drug is packaged in blister packs of 10 and 14 pieces. In each cardboard box There may be 3 or 6 blisters of 10 tablets and 2 blisters of 14.

Description and composition

The active substance of the drug Vestibo is dihydrochloride. Each tablet contains 24 mg of the active element.

Auxiliary components of the tablets are:

• colloidal silicon dioxide;
• povidone;
• stearic acid;
• microcrystalline cellulose;
• crospovidone;
• lactose monohydrate.

Pharmacological group

Vestibo is a drug containing an artificial analogue of the natural mediator histamine. exhibits pronounced activity against H1- and H3-histamine receptors and has a significant vasodilating effect. Compared to the interaction with H1-histamine receptors, the drug exhibits more pronounced antagonism to H3-histamine receptors. As a result of the drug’s effect on the histaminergic system, evoked and spontaneous conduction of impulses from the vestibular structures is suppressed. Due to the direct effect on the H1-histamine receptors of small vessels, the permeability of the capillary wall, blood microcirculation improves and the pressure in the inner ear is stabilized.

The use of Vestibo improves the functioning of the vestibular apparatus, eliminates side noise in the ears and reduces the frequency and intensity of attacks of dizziness. The medication also improves perception in patients with hearing loss. increases the lumen of arterioles and capillaries in the inner ear, which improves blood microcirculation in the brain.

The product does not have sedative or hypnotic properties, and does not affect concentration. Vestibo does not interact with H2-histamine receptors and does not affect the functioning of the glands of the digestive system.

The drug has a high absorption rate from the gastrointestinal tract. The maximum concentration in the blood serum is observed 3 hours after oral administration. The half-life can range from 3 to 4 hours. Excreted via the kidneys.

Indications for use

Vestibo is prescribed to patients with various disorders functioning of the vestibular apparatus. Before use, it is strongly recommended to undergo examination by a doctor to identify contraindications and therapeutic restrictions.

for adults

Application medicinal drug Vestibo is justified in the following conditions:

• pathologies of vestibular and labyrinthine nature, including headache, loss of consciousness, disturbance of spatial orientation, loss of balance, noise and whistling in the ears, nausea and, dizziness and headache, impaired auditory perception;
• vestibular dysfunction caused by infection;
• dropsy of the labyrinth of the inner ear;
• dysfunction of the vestibular apparatus of post-traumatic etiology;
• Meniere's disease;
• Benign paroxysmal positional vertigo (including postoperative cases).

The drug is also used as one of the components of complex treatment of pathologies such as:

• atherosclerosis of blood vessels in the brain;
• post-traumatic encephalopathy;
• vertebrobasilar insufficiency.

for children

For children under 18 years of age, the use of Vestibo is absolutely unacceptable, which is due to insufficient knowledge of the safety and feasibility of treating this group of patients with this drug.

Despite the lack of data on negative impact Vestibo drug on fetal development; use of the medication during the first trimester of pregnancy is strictly contraindicated. During the second and third trimesters, therapeutic use of the drug can only be in cases where the benefit to the mother is several times higher than the risk to the fetus. In this case, the course of treatment should be carried out under the direct supervision of a specialist. During lactation, the use of Vestibo is permitted only after discontinuation of breastfeeding. After completing the course, breastfeeding can be resumed only after 5 days.

Contraindications

Absolute contraindications to the therapeutic use of Vestibo are:

• acute stage of gastric and/or duodenal ulcer;
• pheochromocytoma;
• children under 18 years of age;
• bronchial asthma (including the patient’s tendency to bronchospasm attacks);
• I trimester of pregnancy;
• hypersensitivity to the composition of the drug.

Carefully:

• ulcerative lesions of the stomach and/or duodenum;
• breastfeeding period;
• hypotension;
• II and III trimesters of pregnancy.

Applications and dosages

Vestibo tablets should be taken whole, without chewing, with sufficient volume. clean water. It is recommended to use the product during meals. To achieve the maximum degree of therapeutic effect, it is necessary to entrust the calculation of individual dosages to an experienced specialist.

for adults

The optimal therapeutic dosage of the drug is 8–16 mg 2 to 4 times a day. The amount of the drug used depends on the nature of the pathology, the patient’s body weight, age, degree of tolerance and many other individual factors. The maximum dosage per day is 48 mg.

Desired medicinal effect often occurs after several months of continuous use.

for children

The use of Vestibo is contraindicated for children under 18 years of age.

for pregnant women and during lactation

During the first trimester of pregnancy, it is strictly prohibited to use the medication in therapeutic purposes. Drawing up a dosage regimen and calculating dosages for taking Vestibo during the second and third trimesters of pregnancy should be carried out by the attending physician on a purely individual basis.

During lactation, the drug can be used exclusively in conditions of refusal of breastfeeding.

Side effects

Often patients exhibit high degree drug tolerability. In rare cases, the following reactions may occur while using Vestibo:

• headache;
• dyspepsia;
• itching and rash on the skin;
• Quincke's edema.

Interaction with other drugs

Antihistamines reduce the therapeutic effectiveness of Vestibo.

special instructions

Vestibo does not have a sedative or hypnotic effect, does not reduce cognitive abilities and does not suppress psychomotor skills.

Overdose

IN clinical practice There are no descriptions of an overdose with Vestibo.

Storage conditions

The product is stored in a dark, cool place out of reach of children at a temperature not exceeding 25˚C.

Shelf life – 2 years.

Analogs

Today the following analogues of Vestibo are known:

• Arlevert tablets. Active Ingredients– and dimenhydrinate. It is used exclusively for the treatment of dizziness of various etiologies.
• Cinnaridone tablets. Active substances- And . Has similar properties.
• Aviomarin tablets. The active element is dimenhydrinate. Most often used as a remedy for motion sickness.

  Price

The cost of Vestibo is on average 221 rubles. Prices range from 131 to 369 rubles.

Content

The drug Vestibo is widely used to treat neurological pathologies, dropsy of the labyrinth of the inner ear and labyrinthitis, various dysfunctions of the vestibular apparatus. The medication is prescribed only by the attending physician after full examination and taking anamnesis.

Vestibo composition

The pharmacological agent is available in the form of white or light yellow color, round flat. Packed in aluminum blister of 10 pcs. 1 tablet contains:

pharmachologic effect

The medication is a synthetic analogue of the histamine mediator, has a histamine-like effect, dilates the lumen of blood vessels (vasodilating effect). In addition, betastigine hydrochloride actively affects the cochlear circulation and vestibular apparatus. The therapeutic effect of the drug with long-term use includes vasodilation in the inner ear through its effect on H1 and H3 histamine receptors. The drug inhibits the activity of the vestibular nuclei and the impulsive activity of ampullary receptors.

The drug effect normalizes conductivity in polysynaptic neurons of the vestibular nuclei in the brain stem. Acting indirectly on histamine receptors, it increases the synthesis of serotonin. Vestibo reduces the frequency and intensity of dizziness, reduces tinnitus, and improves hearing.

After oral administration, the active component of the drug is quickly absorbed into the gastrointestinal tract and enters the bloodstream. The maximum concentration is reached after 3 hours. Bioavailability of the active substance is about 75%, binding to plasma proteins is no more than 10%. The drug is metabolized in the liver and excreted by the kidneys within 24 hours. In the presence of chronic diseases urinary system, traces of drug metabolites can be detected in the blood for 5 days.

Indications for use of Vestibo

According to the instructions, the drug Vestibo is widely used for atherosclerosis of small and large vessels, post-traumatic encephalopathies, vertebrobasilar dysfunction. In addition, the drug is indicated for use in the presence of the following pathologies:

• various vestibular and labyrinthine disorders;
• decreased hearing acuity;
• dysfunction of the vestibular apparatus;
• dropsy of the labyrinth;
• pain, tinnitus;
• Meniere's disease.

How to take Vestibo

According to the instructions for use, the tablets should be taken orally during meals, without chewing. For adults, the medication is prescribed in a dosage of 8–16 mg 2–3 times/day. The amount of medication is determined by the attending physician after examination, history taking, and the presence of concomitant pathologies. The dosage can be adjusted depending on the patient’s well-being. The maximum daily dosage of the drug is 48 mg. If there are signs of intolerance, a Vestibo analogue is prescribed for use.

special instructions

In some cases positive effect pharmacological therapy with the use of the drug Vestibo is noticeable after a few months. In case of insufficient liver and kidney function, individual adjustment of single and daily dosages is necessary.

During pregnancy

The pharmacological drug Vestibo is strictly contraindicated for use during the first trimester of pregnancy. According to the instructions for use, from the 13th week until the end of pregnancy, the drug is prescribed under the supervision of a doctor if it is vitally necessary for the mother.

Drug interactions

At simultaneous use with antihistamine drugs, there is a decrease pharmacological action. In addition, enterosorbents reduce the concentration of the drug in the blood, so Vestibo tablets, according to the instructions, should be taken no earlier than 3 hours after using medications of this group.

Side effects of Vestibo

If you do not follow the instructions for using the medication or use it for an excessively long time, the following side effects are possible:

• hypotension;
• dizziness;
• iron deficiency;
• encephalopathy;
• drowsiness.

Overdose

When increasing the single or daily dosage, patients experience a sharp decline blood pressure, dizziness, tachycardia, fainting, hyperemia skin, bronchospasm, nausea. If signs of overdose appear, according to the instructions, you should rinse your stomach, stop using the medication, take enterosorbent and consult a doctor.

Contraindications

The medication should be prescribed with caution in the presence of chronic peptic ulcer disease, oncological pathologies of the hematopoietic system, and in children under 18 years of age. According to the instructions, absolute contraindications include:

• bronchial asthma;
• pheochromocytoma;
• hypersensitivity to the components of the drug;
• tuberculosis;
• atherosclerosis;
• acute renal failure;
• mechanical damage to the esophagus or upper sections respiratory system.

Terms of sale and storage

According to the instructions, Vestibo tablets are available with a doctor's prescription. According to the instructions, the medicine should be stored in a dry place, protected from direct sun rays. The shelf life of the medicine is 3 years from the date of release.

Analogs

In the presence of absolute contraindications Before using a medication, a specialist selects a drug that is similar in action and instructions for use. These include:

Drug name	pharmachologic effect	Indications for use	Contraindications	Jamming action	Cost in rubles
Vesticap	vasodilating; histamine-like.	Minière's disease; dizziness; noise in ears; labyrinthitis; encephalopathy;	pregnancy; childhood; bronchial asthma; tendency to bronchospasms; renal failure;	angioedema; loss of coordination of movements; headache; dizziness.
	vasodilating; analgesic; histamine-like.	Minière's disease; dizziness; noise in ears; headache; labyrinthitis; vertebrobasilar insufficiency.	viral hepatitis; cirrhosis of the liver; pancreatic necrosis; pregnancy; childhood; hypersensitivity to the drug.	angioedema; loss of consciousness; dizziness.
Betaserk	vasodilating; hypotensive; histamine-like.	Minière's disease; dizziness; labyrinthitis; atherosclerosis of cerebral vessels; vertebrobasilar insufficiency.	exacerbation of peptic ulcer; gastrointestinal bleeding; childhood; bronchial asthma; predisposition to bronchospasms.	headache; confusion; loss of coordination of movements; dizziness.
	vasodilating; histamine-like.	headache; dizziness; noise in ears; labyrinthitis; vertebrobasilar insufficiency.	pregnancy; childhood; bronchial asthma; hypersensitivity to the drug.	angioedema; decreased blood pressure; dizziness.
Betacentrin	histamine-like.	Minière's disease; headache; dizziness; noise in ears; labyrinthitis; encephalopathy; atherosclerosis of cerebral vessels; vertebrobasilar insufficiency.	pregnancy; open form of tuberculosis; pancreatic necrosis; childhood; bronchial asthma; hypersensitivity to the drug.	decreased blood pressure; incoordination of movements; nausea; vomit; loss of appetite; dizziness.
Microzer	vasodilating; hypotensive; histamine-like.	Minière's disease; dizziness; noise in ears; labyrinthitis; swelling of the external ear canal; encephalopathy; atherosclerosis of the arteries and capillaries of the brain.	pregnancy in the first trimester; oncological pathologies; open form of tuberculosis; childhood; bronchial asthma; hypersensitivity to the drug.	angioedema; drowsiness; decreased blood pressure; dizziness.
Vazoserk	hypotensive; histamine-like.	increased intracranial pressure; swelling of the external ear canal; encephalopathy; atherosclerosis of cerebral vessels;	exacerbation of peptic ulcer; pregnancy; childhood; bronchial asthma; hypersensitivity to the drug.	decreased blood pressure; drowsiness; loss of appetite; dizziness.
	vasodilating; histamine-like.	Minière's disease; dizziness; noise in ears; atherosclerosis of cerebral vessels; vertebrobasilar insufficiency.	pregnancy; childhood; bronchial asthma; hypersensitivity to the drug.	angioedema; decreased blood pressure; dizziness.
Betastigin	histamine-like.	hydrocephalus; swelling of the external ear canal; encephalopathy; vertebrobasilar insufficiency.	acute renal failure; bronchial asthma; hypersensitivity to the drug.	angioedema; dizziness.
	vasodilating; hypotensive; histamine-like.	increased intracranial pressure; dizziness; noise in ears; labyrinthitis; congenital encephalopathy; dropsy of the brain; atherosclerosis of cerebral vessels; vertebrobasilar insufficiency.	pregnancy; childhood; gastrointestinal bleeding; cirrhosis of the liver; hypersensitivity to the drug.	angioedema; headache; decreased blood pressure; Found an error in the text? Select it, press Ctrl + Enter and we will fix everything!